Tacrolimus Dose Variability, CYP3A5 Genotype, and Acute Rejection in African American and European American Kidney Transplant Recipients

被引：0
|
作者：
Seibert, S. [1 ]
Schladt, D. [2 ]
Wu, B. [3 ]
Guan, W. [3 ]
Dorr, C. [2 ,7 ]
Berglund, D. [1 ]
Remmel, R. [4 ]
Matas, A. [5 ]
Mannon, R. [6 ]
Israni, A. [2 ,7 ]
Oetting, W. [1 ]
Jacobson, P. [1 ]
机构：
[1] Univ Minnesota UMN, Dept Expt & Clin Pharmacol, Coll Pharm, Minneapolis, MN USA
[2] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN USA
[3] UMN, Div Biostat, Sch Publ Hlth, Minneapolis, MN USA
[4] UMN, Dept Med Chem, Coll Pharm, Minneapolis, MN USA
[5] UMN, Div Transplantat, Dept Surg, Sch Med, Minneapolis, MN USA
[6] Univ Alabama Birmingham, Dept Nephrol, Birmingham, AL USA
[7] UMN, Dept Nephrol, Hennepin Cty Med Ctr, Sch Med, Minneapolis, MN USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D65
引用
收藏
页码：732 / 732
页数：1
相关论文
共 50 条
  • [1] Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients
    Seibert, Stephan R.
    Schladt, David P.
    Wu, Baolin
    Guan, Weihua
    Dorr, Casey
    Remmel, Rory P.
    Matas, Arthur J.
    Mannon, Roslyn B.
    Israni, Ajay K.
    Oetting, William S.
    Jacobson, Pamala A.
    [J]. CLINICAL TRANSPLANTATION, 2018, 32 (12)
  • [2] TACROLIMUS POPULATION PHARMACOKINETICS AND CYP3A5 GENOTYPES IN AFRICAN AMERICAN AND CAUCASIAN RENAL TRANSPLANT RECIPIENTS
    Campagne, O.
    Mager, D. E.
    Brazeau, D.
    Venuto, R. C.
    Tornatore, K. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S18 - S18
  • [3] Clinical impact of reassessed tacrolimus starting dose according to CYP3A5 genotype in kidney transplant recipients
    Largeau, B.
    Barin-Le Guellec, C.
    Longuet, H.
    Lesne, P.
    Bouvarel, A.
    Preteseille, L.
    Halimi, J. M.
    Buchler, M.
    Gatault, P.
    Noble, J.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 38 - 38
  • [4] Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles
    Oetting, W. S.
    Schladt, D. P.
    Guan, W.
    Miller, M. B.
    Remmel, R. P.
    Dorr, C.
    Sanghavi, K.
    Mannon, R. B.
    Herrera, B.
    Matas, A. J.
    Salomon, D. R.
    Kwok, P. Y.
    Keating, B. J.
    Israni, A. K.
    Jacobson, P. A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (02) : 574 - 582
  • [5] Influence of the Cyp3a5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients
    Ferraresso, Mariano
    Tirelli, Amedea
    Ghio, Luciana
    Grillo, Paolo
    Martina, Valentina
    Torresani, Erminio
    Edefonti, Alberto
    [J]. PEDIATRIC TRANSPLANTATION, 2007, 11 (03) : 296 - 300
  • [6] CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipients
    Renders, L.
    Frisman, M.
    Ufer, M.
    Mosyagin, I.
    Haenisch, S.
    Ott, U.
    Caliebe, A.
    Dechant, M.
    Braun, F.
    Kunzendorf, U.
    Cascorbi, I.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) : 228 - 234
  • [7] CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
    Hesselink, Dennis A.
    van Schaik, Ron H. N.
    van Agteren, Madelon
    de Fijter, Johannes W.
    Hartmann, Anders
    Zeier, Martin
    Budde, Klemens
    Kuypers, Dirk R. J.
    Pisarski, Przemyslav
    Le Meur, Yann
    Mamelok, Richard D.
    van Gelder, Teun
    [J]. PHARMACOGENETICS AND GENOMICS, 2008, 18 (04): : 339 - 348
  • [8] CYP3A5 Genotype Had no Impact on Intrapatient Variability of Tacrolimus Clearance in Renal Transplant Recipients
    Spierings, N.
    Holt, D. W.
    MacPhee, Iain A. M.
    [J]. THERAPEUTIC DRUG MONITORING, 2013, 35 (03) : 328 - 331
  • [9] CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients
    Yanik, Megan V.
    Seifert, Michael E.
    Locke, Jayme E.
    Hauptfeld-Dolejsek, Vera
    Crowley, Michael R.
    Cutter, Gary R.
    Mannon, Roslyn B.
    Feig, Daniel I.
    Limdi, Nita A.
    [J]. PEDIATRIC TRANSPLANTATION, 2019, 23 (05)
  • [10] Comparison of Tacrolimus Starting Doses Based on CYP3A5 Phenotype or Genotype in Kidney Transplant Recipients
    Largeau, Berenger
    Barin-Le Guellec, Chantal
    Longuet, Helene
    Lesne, Philippe
    Bouvarel, Antoine
    Preteseille, Laura
    Marquet, Pierre
    Halimi, Jean-Michel
    Buchler, Matthias
    Gatault, Philippe
    Noble, Johan
    [J]. PROGRESS IN TRANSPLANTATION, 2019, 29 (04) : 300 - 308
12345